Determinants of societal costs in Alzheimer's disease: GERAS study baseline results-Reference-Cited by-同舟云学术

Determinants of societal costs in Alzheimer's disease: GERAS study baseline results

Published:2015-04-03 Issue:8 Volume:11 Page:933-945
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Dodel Richard¹,Belger Mark²,Reed Catherine²,Wimo Anders³,Jones Roy W.⁴,Happich Michael²,Argimon Josep M.⁵,Bruno Giuseppe⁶,Vellas Bruno⁷,Haro Josep Maria⁸

Affiliation:

1. Department of Neurology Philipps‐University Marburg Germany

2. Eli Lilly and Company Limited Lilly Research Centre Windlesham, Surrey UK

3. Division of Neurogeriatrics Department of Neurobiology, Care Sciences and Society Karolinska Institute Stockholm Sweden

4. RICE ‐ The Research Institute for the Care of Older People, The RICE Centre Royal United Hospital Bath UK

5. Agencia Qualitat i Avaluació Sanitaries Barcelona Spain

6. Clinica della Memoria Department of Neurological Sciences University of Rome “Sapienza” Rome Italy

7. Gerontopole, Alzheimer's Disease Research and Clinical Center, INSERM 1027 Toulouse University Hospital Toulouse France

8. Parc Santari Sant Joan de Déu, CIBERSAM Universitat de Barcelona Sant Boi de Llobregat, Barcelona Spain

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.02.005

Reference35 articles.

1. The global prevalence of dementia: A systematic review and metaanalysis

2. Implications of the Facing Dementia Survey for policy makers and third‐party organisations across Europe;Rimmer E;Int J Clin Pract,2005

3. Alzheimer's Disease International.World Alzheimer Report 2010.The global economic impact of dementia. Available at:http://www.alz.co.uk/research/world‐report. Accessed July 9 2013.

4. The worldwide economic impact of dementia 2010

5. The economic cost of brain disorders in Europe

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Personal Wealth Indicators and Health Care Costs in Persons With Alzheimer's Disease;Journal of the American Medical Directors Association;2023-12

2. Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity;PharmacoEconomics - Open;2023-11-15

3. Apathy in patients with Alzheimer's disease is a cost‐driving factor;Alzheimer's & Dementia;2023-01-02

4. The Costs of Dementia in Europe: An Updated Review and Meta-analysis;PharmacoEconomics;2022-11-15

5. International depiction of the cost of functional independence limitations among older adults living in the community: a systematic review and cost-of-impairment study;BMC Geriatrics;2022-10-22